The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
Here's a roundup of top developments in the biotech space over the last 24 hours.
Earnings Scheduled For November 10, 2021
Companies Reporting Before The Bell
• LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.
Barclays Maintains Overweight on Sotera Health, Raises Price Target to $32
Barclays analyst Luke Sergott maintains Sotera Health (NASDAQ:SHC) with a Overweight and raises the price target from $30 to $32.
Sotera Health Q2 EPS $0.26 Beats $0.21 Estimate, Sales $252.00M Beat $227.21M Estimate
Sotera Health (NASDAQ:SHC) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.21 by 23.81 percent. The company reported quarterly sales of $252.00 million which beat the
Earnings Scheduled For August 12, 2021
Companies Reporting Before The Bell
• Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.
Earnings Scheduled For May 13, 2021
Companies Reporting Before The Bell
• CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million.